The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Open accessAbstract
The spontaneous deamination of cytosine is a major source of transitions from C•G to T•A base pairs, which account for half of known pathogenic point mutations in humans. The ability to efficiently convert targeted A•T base pairs to G•C could therefore advance the study and treatment of genetic diseases. The deamination of adenine yields inosine, which is treated as guanine by polymerases, but no enzymes are known to deaminate adenine in DNA. Here we describe adenine base editors (ABEs) that mediate the conversion of A•T to G•C in genomic DNA. We evolved a transfer RNA adenosine deaminase to operate on DNA when fused to a catalytically impaired CRISPR-Cas9 mutant. Extensive directed evolution and protein engineering resulted in seventh-generation ABEs that convert targeted A•T base pairs efficiently to G•C (approximately 50% efficiency in human cells) with high product purity (typically at least 99.9%) and low rates of indels (typically no more than 0.1%). ABEs introduce point mutations more efficiently and cleanly, and with less off-target genome modification, than a current Cas9 nuclease-based method, and can install disease-correcting or disease-suppressing mutations in human cells. Together with previous base editors, ABEs enable the direct, programmable introduction of all four transition mutations without double-stranded DNA cleavage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using a seventh-generation evolved transfer RNA adenosine deaminase attached to dCas9, researchers demonstrated conversion of A*T base pairs to G*C base pairs in a targeted fashion at efficiencies of around 50% with few undesired mutations in human cells.”
From Delivering CRISPR: a review of the challenges and approaches (2018) · cites this paper as Gaudelli et al., 2017
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Adenine base editor (ABE), first described in 2017, generally does not induce DSBs (<1%) and is therefore a favorable alternative to Cas9 for single and multiplex gene knockouts.12,14”
From Adenine base editor for knockout of proteins: A practical guide from design to analysis with updated MultiEditRbatch (2026) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Yet, these mutations occur significantly more often in human disease than transversion mutations (62% transition vs 38% transversion29,63).”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Gaudelli et al., 2017
The cited source says what the claim attributes to it.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“Fusing adenine deaminase (an evolved TadA heterodimer) to a nickase-Cas9 creates an adenine base editor (ABE) that mediates A > G base changes via an inosine intermediate29”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [29]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [49]
Experimental — accuracy not yet measuredIn the citing paper
“Consistent with the literature1, ABE6.3 resulted in the highest A>G base editing efficiency at position A9 (6.9 ± 2.0%,2 µg ABE6.3) (Supplementary Fig. 1) and editing efficiency was dependent of the ABE enzyme concentration.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Adenine BEs comprise an evolved Escherichia coli TadA (ecTadA*, a tRNA adenosine deaminase evolved to accept DNA substrate) and Cas9 nickase, and mediate A•T to G•C substitutions1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“The ABE editing window occupies positions ~4–9 with the 1st, 5’ nucleotide (nt) of the candidate sgRNA counted as position 1 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
In the citing paper
“Point mutations are a frequent cause of genetic disease, with ~50% of disease point mutations being G:C>A:T 1.”
From Adenine base editing in an adult mouse model of tyrosinaemia (2019) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
Self-citationClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems
Nishida, K., Arazoe, T., Yachie, N., Banno, S., Kakimoto, M., Tabata, M., Mochizuki, M., Miyabe, A., Araki, M., Hara, K. Y., et al. (2016) · Science · doi:10.1126/science.aaf8729 · Cited by 1,349
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion
Zong, Y., Wang, Y., Li, C., Zhang, R., Chen, K., Ran, Y., Qiu, J., Wang, D., & Gao, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3811 · Cited by 896
Komor, A. C., Zhao, K. T., Packer, M. S., Gaudelli, N. M., Waterbury, A. L., Koblan, L. W., Kim, Y. B., Badran, A. H., & Liu, D. R. (2017) · Science Advances · doi:10.1126/sciadv.aao4774 · Cited by 783
Self-citationKim, Y. B., Komor, A. C., Levy, J. M., Packer, M. S., Zhao, K. T., & Liu, D. R. (2017) · Nature Biotechnology · doi:10.1038/nbt.3803 · Cited by 758
Self-citationA system for the continuous directed evolution of biomolecules
Esvelt, K. M., Carlson, J. C., & Liu, D. R. (2011) · Nature · doi:10.1038/nature09929 · Cited by 694
Self-citationUracil in DNA – occurrence, consequences and repair
Krokan, H. E., Drabløs, F., & Slupphaug, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205996 · Cited by 500
Cited by
Sorted by citations
Items 801–900 of 1,024
Prime Editing for Human Gene Therapy: Where Are We Now?
Godbout, K., & Tremblay, J. P. (2023) · Cells · doi:10.3390/cells12040536 · Cited by 56
Integration of ζ-deficient CARs into the CD3 ζ gene conveys potent cytotoxicity in T and NK cells
Kath, J., Franke, C., Drosdek, V., Du, W., Glaser, V., Fuster‐García, C., Stein, M., Zittel, T., Schulenberg, S., Porter, C. E., et al. (2024) · Blood · doi:10.1182/blood.2023020973 · Cited by 52
Bollen, Y., Post, J. B., Koo, B., & Snippert, H. J. G. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky571 · Cited by 53
Molla, K. A., Shih, J., & Yang, Y. (2020) · aBIOTECH · doi:10.1007/s42994-020-00018-x · Cited by 52
Sretenovic, S., Yin, D., Levav, A., Selengut, J., Mount, S. M., & Qi, Y. (2020) · Plant Communications · doi:10.1016/j.xplc.2020.100101 · Cited by 53
CRISPR/Cas9 in Cancer Immunotherapy: Animal Models and Human Clinical Trials
Khalaf, K., Janowicz, K., Dyszkiewicz-Konwińska, M., Hutchings, G., Dompé, C., Moncrieff, L., Jankowski, M., Machnik, M., Oleksiewicz, U., Kocherova, I., et al. (2020) · Genes · doi:10.3390/genes11080921 · Cited by 52
Gene Therapy Developments for Pompe Disease
Unnisa, Z., Yoon, J. K., Schindler, J. W., Mason, C., & van Til, N. P. (2022) · Biomedicines · doi:10.3390/biomedicines10020302 · Cited by 53
A CRISPR way for accelerating cereal crop improvement: Progress and challenges
Basu, U., Riaz Ahmed, S., Bhat, B. A., Anwar, Z., Ali, A., Ijaz, A., Gulzar, A., Bibi, A., Tyagi, A., Nebapure, S. M., et al. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2022.866976 · Cited by 51
Jeong, Y. K., Yu, J., & Bae, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-41356-1 · Cited by 51
Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
Bastola, P., Song, L., Gilger, B. C., & Hirsch, M. L. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080767 · Cited by 52
Rittiner, J. E., Moncalvo, M., Chiba‐Falek, O., & Kantor, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00148 · Cited by 53
Knipping, F., Newby, G. A., Eide, C. R., McElroy, A. N., Nielsen, S. C., Smith, K. D., Fang, Y., Cornu, T. I., Costa, C., Gutiérrez-Guerrero, A., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.10.026 · Cited by 53
Self-citationRNA-targeting strategies as a platform for ocular gene therapy
Kumar, S., Fry, L. E., Wang, J.-H., Martin, K. R., Hewitt, A. W., Chen, F. K., & Liu, G.-S. (2023) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2022.101110 · Cited by 51
Gene therapy for cystic fibrosis: Challenges and prospects
Sui, H., Xu, X., Su, Y., Gong, Z., Yao, M., Liu, X., Zhang, T., Jiang, Z., Bai, T., Wang, J., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1015926 · Cited by 56
High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications
Seo, H., Jeon, L., Kwon, J., & Lee, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203033 · Cited by 54
A highly specific CRISPR-Cas12j nuclease enables allele-specific genome editing
Wang, Y., Qi, T., Liu, J., Yang, Y., Wang, Z., Wang, Y., Wang, T., Li, M., Li, M., Lu, D., et al. (2023) · Science Advances · doi:10.1126/sciadv.abo6405 · Cited by 56
Sufyan, M., Daraz, U., Hyder, S., Zulfiqar, U., Iqbal, R., Eldin, S. M., Rafiq, F., Mahmood, N., Shahzad, K., Uzair, M., et al. (2023) · Functional & Integrative Genomics · doi:10.1007/s10142-023-01036-w · Cited by 55
Retron-mediated multiplex genome editing and continuous evolution in Escherichia coli
Liu, W., Zuo, S., Shao, Y., Bi, K., Zhao, J., Huang, L., Xu, Z., & Lian, J. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad607 · Cited by 53
In vivo prime editing rescues alternating hemiplegia of childhood in mice
Sousa, A. A., Terrey, M., Sakai, H. A., Simmons, C. Q., Arystarkhova, E., Morsci, N. S., Anderson, L. C., Xie, J., Suri‐Payer, F., Laux, L. C., et al. (2025) · Cell · doi:10.1016/j.cell.2025.06.038 · Cited by 54
Self-citationO’Brien, C. E., Roumbedakis, K., & Winkelmann, I. E. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00700 · Cited by 53
Impact of CRISPR interference on strain development in biotechnology
Schultenkämper, K., Brito, L. F., & Wendisch, V. F. (2020) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.1901 · Cited by 57
CRISPR base editing and prime editing: DSB and template-free editing systems for bacteria and plants
Abdullah, A., Jiang, Z., Hong, X., Zhang, S., Yao, R., & Xiao, Y. (2020) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2020.08.003 · Cited by 52
Kalds, P., Luo, Q., Sun, K., Zhou, S., Chen, Y., & Wang, X. (2021) · Animal Genetics · doi:10.1111/age.13133 · Cited by 51
CRISPR-Cas9 to induce fetal hemoglobin for the treatment of sickle cell disease
Demirci, S., Leonard, A. K., Essawi, K., & Tisdale, J. F. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.09.010 · Cited by 56
Advances in the regulation of plant development and stress response by miR167
Liu, X., Huang, S., & Xie, H. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4974 · Cited by 50
Kim, S., Choi, M., Bae, S., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111389 · Cited by 50
Ali, Q., Yu, C., Hussain, A., Ali, M., Ahmar, S., Sohail, M. A., Riaz, M., Ashraf, M. F., Abdalmegeed, D., Wang, X., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.860281 · Cited by 53
In the business of base editors: Evolution from bench to bedside
Porto, E. M., & Komor, A. C. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002071 · Cited by 53
Self-citationProgress and Perspective of CRISPR‐Cas9 Technology in Translational Medicine
Zheng, R., Zhang, L., Parvin, R., Su, L., Chi, J., Shi, K., Ye, F., & Huang, X. (2023) · Advanced Science · doi:10.1002/advs.202300195 · Cited by 56
The expanded CRISPR toolbox for constructing microbial cell factories
Teng, Y., Jiang, T., & Yan, Y. (2023) · Trends in biotechnology · doi:10.1016/j.tibtech.2023.06.012 · Cited by 51
Brooks, D. L., Whittaker, M. N., Qü, P., Musunuru, K., Ahrens‐Nicklas, R. C., & Wang, X. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.10.005 · Cited by 50
Ribozyme-activated mRNA trans-ligation enables large gene delivery to treat muscular dystrophies
Lindley, S. R., Subbaiah, K. C. V., Priyanka, F., Poosala, P., Ma, Y., Jalinous, L., West, J. A., Richardson, W. A., Thomas, T. N., & Anderson, D. M. (2024) · Science · doi:10.1126/science.adp8179 · Cited by 50
Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes
Soyars, C. L., Peterson, B. A., Burr, C. A., & Nimchuk, Z. L. (2018) · Plant and Cell Physiology · doi:10.1093/pcp/pcy079 · Cited by 50
Therapeutic Genome Editing in Cardiovascular Diseases
German, D. M., Mitalipov, S. M., Mishra, A., & Kaul, S. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.11.004 · Cited by 52
Base Editing Landscape Extends to Perform Transversion Mutation
Molla, K. A., Qi, Y., Karmakar, S., & Baig, M. J. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.09.001 · Cited by 50
Development of an efficient plant dual cytosine and adenine editor
Xu, R., Kong, F., Qin, R., Li, J., Liu, X., & Wei, P. (2021) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13146 · Cited by 51
Modern therapeutic approaches to liver-related disorders
Gardin, A., Remih, K., Gonzales, E. M., Andersson, E. R., & Strnad, P. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.015 · Cited by 51
Base editors: Expanding the types of DNA damage products harnessed for genome editing
Gu, S., Bodai, Z., Cowan, Q. T., & Komor, A. C. (2021) · Gene and Genome Editing · doi:10.1016/j.ggedit.2021.100005 · Cited by 50
Self-citationMassively parallel assessment of human variants with base editor screens
Hanna, R. E., Hegde, M., Fagre, C. R., DeWeirdt, P. C., Sangree, A. K., Szegletes, Z., Griffith, A., Feeley, M. N., Sanson, K. R., Baidi, Y., et al. (2020) · doi:10.1101/2020.05.17.100818 · Cited by 314
“CRISPR base editors (Gaudelli et al., 2017; Komor et al., 2016), which introduce transition mutations at target loci, are an attractive candidate for sub-saturating variant screening for several reasons.”
Kondo, K., & Taguchi, C. (2022) · Food Safety · doi:10.14252/foodsafetyfscj.d-21-00016 · Cited by 49
Qiu, Y., Lei, P., Wang, R., Sun, L. D., Luo, Z., Li, S., & Xu, H. L. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108125 · Cited by 50
Genome editing in the treatment of ocular diseases
Choi, E. H., Suh, S., Sears, A. E., Hołubowicz, R., KEDHAR, S. R., Browne, A., & Palczewski, K. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01057-2 · Cited by 51
Recent Therapeutic Gene Editing Applications to Genetic Disorders
Deneault, É. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050255 · Cited by 54
Schoonenberg, V. A. C., Cole, M. A., Yao, Q., Macias-Treviño, C., Sher, F., Schupp, P. G., Canver, M. C., Maeda, T., Pinello, L., & Bauer, D. E. (2018) · Genome biology · doi:10.1186/s13059-018-1563-5 · Cited by 49
Park, J. E., & Silva, A. C. (2018) · American Journal of Primatology · doi:10.1002/ajp.22931 · Cited by 51
Implementation of a CRISPR-Based System for Gene Regulation in Candida albicans
Román, E., Coman, I., Prieto, D., Alonso‐Monge, R., & Plá, J. (2019) · mSphere · doi:10.1128/msphere.00001-19 · Cited by 49
Cruz, E. R., Nguyen, H., Nguyen, T., & Wallace, I. S. (2019) · The Plant Journal · doi:10.1111/tpj.14372 · Cited by 49
Strategies for the CRISPR-Based Therapeutics
Li, B., Niu, Y., Ji, W., & Dong, Y. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.11.006 · Cited by 52
Catalytic-state structure and engineering of Streptococcus thermophilus Cas9
Zhang, Y., Zhang, H., Xu, X., Wang, Y., Chen, W., Wang, Y., Wu, Z., Tang, N., Wang, Y., Zhao, S., et al. (2020) · Nature Catalysis · doi:10.1038/s41929-020-00506-9 · Cited by 49
Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies
Almughem, F. A., Aldossary, A. M., Tawfik, E. A., Alomary, M. N., Alharbi, W. S., Alshahrani, M. Y., & Alshehri, A. A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12070616 · Cited by 53
Bigini, V., Camerlengo, F., Botticella, E., Sestili, F., & Savatin, D. V. (2021) · Plants · doi:10.3390/plants10061146 · Cited by 52
Packer, M. S., Chowdhary, V., Lung, G., Cheng, L.-I., Aratyn-Schaus, Y., Leboeuf, D., Smith, S., Shah, A. A., Chen, D. L., Zieger, M. V., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.040 · Cited by 48
Self-citationImproving Homology-Directed Repair in Genome Editing Experiments by Influencing the Cell Cycle
Smirnikhina, S., Zaynitdinova, M. I., Sergeeva, V. A., & Лавров, А. В. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115992 · Cited by 54
New advances in CRISPR/Cas-mediated precise gene-editing techniques
Richardson, C., Kelsh, R. N., & Richardson, R. J. (2023) · Disease Models & Mechanisms · doi:10.1242/dmm.049874 · Cited by 48
AI-generated MLH1 small binder improves prime editing efficiency
Park, J.-C., Uhm, H., Kim, Y. W., Oh, Y. E., Lee, J., Yang, J., Kim, K., & Bae, S. (2025) · Cell · doi:10.1016/j.cell.2025.07.010 · Cited by 50
Precise A•T to G•C base editing in the zebrafish genome
Qin, W., Lu, X., Liu, Y., Bai, H., Li, S., & Lin, S. (2018) · BMC Biology · doi:10.1186/s12915-018-0609-1 · Cited by 48
Development of drug-inducible CRISPR-Cas9 systems for large-scale functional screening
Sun, N., Petiwala, S. M., Wang, R., Lu, C., Hu, M., Ghosh, S., Hao, Y., Miller, C. P., & Chung, N. (2019) · BMC Genomics · doi:10.1186/s12864-019-5601-9 · Cited by 49
New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes
Kawall, K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00525 · Cited by 50
Editing the Central Nervous System Through CRISPR/Cas9 Systems
Cota-Coronado, A., Díaz-Martínez, N. F., Padilla‐Camberos, E., & Diaz-Martinez, N. E. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00110 · Cited by 51
O’Brien, A. R., Wilson, L. O. W., Burgio, G., & Bauer, D. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-39142-0 · Cited by 48
Wang, K., Gong, Q., & Ye, X. (2019) · Theoretical and Applied Genetics · doi:10.1007/s00122-019-03464-4 · Cited by 49
Monsur, M. B., Shao, G., Lv, Y., Ahmad, S., Wei, X., Hu, P., & Tang, S. (2020) · Genes · doi:10.3390/genes11040466 · Cited by 48
Reprogramming Acetogenic Bacteria with CRISPR-Targeted Base Editing via Deamination
Xia, P., Casini, I., Schulz, S., Klask, C.-M., Angenent, L. T., & Molitor, B. (2020) · ACS Synthetic Biology · doi:10.1021/acssynbio.0c00226 · Cited by 50
Fry, L. E., McClements, M. E., & MacLaren, R. E. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.6418 · Cited by 49
Lyu, P., Lu, Z., Cho, S.-I., Yadav, M., Yoo, K. W., Atala, A., Kim, J., & Lu, B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0095 · Cited by 50
Lentiviral vectors for ocular gene therapy
Arsenijevic, Y., Berger, A., Udry, F., & Kostic, C. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081605 · Cited by 47
Concerns regarding ‘off-target’activity of genome editing endonucleases
Kadam, U. S., Shelake, R. M., Chavhan, R. L., & Suprasanna, P. (2018) · Plant Physiology and Biochemistry · doi:10.1016/j.plaphy.2018.03.027 · Cited by 47
The Future of In Utero Gene Therapy
Peranteau, W. H., & Flake, A. W. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00445-y · Cited by 47
Recent advances in genome editing of stem cells for drug discovery and therapeutic application
Lee, J., Bayarsaikhan, D., Bayarsaikhan, G., Kim, J., Schwarzbach, E., & Lee, B. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107501 · Cited by 48
Modeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 49
Current status of the application of gene editing in pigs
Tanihara, F., Hirata, M., & Otoi, T. (2021) · Journal of Reproduction and Development · doi:10.1262/jrd.2021-025 · Cited by 49
Understanding and Exploiting Post-Translational Modifications for Plant Disease Resistance
Gough, C., & Sadanandom, A. (2021) · Biomolecules · doi:10.3390/biom11081122 · Cited by 47
CRISPR-Based Genome Editing: Advancements and Opportunities for Rice Improvement
Zegeye, W. A., Tsegaw, M., Zhang, Y., & Cao, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084454 · Cited by 49
Recent advancements in CRISPR/Cas technology for accelerated crop improvement
Das, D., Singha, D. L., Paswan, R. R., Chowdhury, N., Sharma, M., Reddy, P. S., & Chikkaputtaiah, C. (2022) · Planta · doi:10.1007/s00425-022-03894-3 · Cited by 50
Tsai, C.-W., Rodriguez, M. X., Keuren, A. M. V., Phillips, C. B., Shushunov, H. M., Lee, J. E., Garcia, A. M., Ambardekar, A. V., Cleveland, J. C., Reisz, J. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.006 · Cited by 47
Leveraging a natural murine meiotic drive to suppress invasive populations
Gierus, L., Birand, A., Bunting, M. D., Godahewa, G., Piltz, S. G., Oh, K. P., Piaggio, A., Threadgill, D., Godwin, J., Edwards, O., et al. (2022) · bioRxiv · doi:10.1073/pnas.2213308119 · Cited by 43
Continuous directed evolution of a compact CjCas9 variant with broad PAM compatibility
Schmidheini, L., Mathis, N., Marquart, K. F., Rothgangl, T., Kissling, L., Böck, D., Chanez, C., Wang, J. P., Jínek, M., & Schwank, G. (2023) · Nature Chemical Biology · doi:10.1038/s41589-023-01427-x · Cited by 49
Palacios, A. M., Korus, P., Wilkens, B. G. C., Heshmatpour, N., & Patnaik, S. R. (2024) · Frontiers in Genome Editing · doi:10.3389/fgeed.2024.1342193 · Cited by 49
The design and engineering of synthetic genomes
James, J. S., Dai, J., Chew, W. L., & Cai, Y. (2024) · Nature Reviews Genetics · doi:10.1038/s41576-024-00786-y · Cited by 52
An Engineered Cas-Transposon System for Programmable and Site-Directed DNA Transpositions
Chen, S. P., & Wang, H. H. (2019) · The CRISPR Journal · doi:10.1089/crispr.2019.0030 · Cited by 47
Advances in actinomycete research: an ActinoBase review of 2019
Prudence, S. M. M., Addington, E., Castaño-Espriu, L., Mark, D. R., Escobar, L., Russell, A. H., & McLean, T. C. (2020) · Microbiology · doi:10.1099/mic.0.000944 · Cited by 47
Khadka, K., Raizada, M. N., & Navabi, A. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.01149 · Cited by 47
Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease
Joseph, S. A., Taglialatela, A., Leuzzi, G., Huang, J., Cuella-Martin, R., & Ciccia, A. (2020) · DNA repair · doi:10.1016/j.dnarep.2020.102943 · Cited by 48
Huang, C., Li, G., Wu, J., Liang, J., & Wang, X. (2021) · Genome biology · doi:10.1186/s13059-021-02305-2 · Cited by 48
Plant genome editing: ever more precise and wide reaching
Sukegawa, S., Saika, H., & Toki, S. (2021) · The Plant Journal · doi:10.1111/tpj.15233 · Cited by 48
Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
Zhang, X., Li, T., Ou, J., Huang, J., & Liang, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00838-7 · Cited by 47
Moving toward genome-editing therapies for cardiovascular diseases
Musunuru, K. (2022) · Journal of Clinical Investigation · doi:10.1172/jci148555 · Cited by 48
ABE8e adenine base editor precisely and efficiently corrects a recurrent COL7A1 nonsense mutation
Sheriff, A., Guri, I., Żebrowska-Różańska, P., Llopis-Hernández, V., Brooks, I. R., Tekkela, S., Subramaniam, K. S., Gebrezgabher, R., Naso, G., Petrova, A., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-24184-8 · Cited by 49
Self-citationHighly efficient base editing with expanded targeting scope using SpCas9‐NG in rabbits
Liu, Z., Shan, H., Chen, S., Chen, M., Song, Y., Lai, L., & Li, Z. (2019) · The FASEB Journal · doi:10.1096/fj.201901587r · Cited by 46
Therapeutic homology-independent targeted integration in retina and liver
Tornabene, P., Ferla, R., Llado-Santaeularia, M., Centrulo, M., Dell’Anno, M., Esposito, F., Marrocco, E., Pone, E., Minopoli, R., Iodice, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29550-8 · Cited by 48
CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
Chemello, F., Olson, E. N., & Bassel‐Duby, R. (2023) · Human Gene Therapy · doi:10.1089/hum.2023.053 · Cited by 47
Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
Zhang, Y., Chen, S., Yang, L., & Zhang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1169884 · Cited by 48
Ravichandran, M., & Maddalo, D. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1273994 · Cited by 47
Mitochondrial genome editing: strategies, challenges, and applications
Lim, K. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0224 · Cited by 47
Precise fine-turning of GhTFL1 by base editing tools defines ideal cotton plant architecture
Wang, G., Wang, F., Xu, Z., Wang, Y., Zhang, C., Zhou, Y., Hui, F., Yang, X., Nie, X., Zhang, X., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03189-8 · Cited by 46
Vishy, C. E., Thomas, C. J., Vincent, T., Crawford, D. K., Goddeeris, M. M., & Freedman, B. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.03.005 · Cited by 47
CRISPR/Cas system: A game changing genome editing technology, to treat human genetic diseases
Hussain, W., Mahmood, T., Hussain, J. S., Ali, N., Shah, T. M., Qayyum, S., & Khan, I. (2018) · Gene · doi:10.1016/j.gene.2018.10.072 · Cited by 46
Dandage, R., Després, P. C., Yachie, N., & Landry, C. R. (2019) · Genetics · doi:10.1534/genetics.119.302089 · Cited by 46
Wang, Y., Zhou, L., Liu, N., & Yao, S. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0072-7 · Cited by 46
CRISPR/Cas9-deaminase enables robust base editing in Rhodobacter sphaeroides 2.4.1
Luo, Y., Ge, M., Wang, B., Sun, C., Wang, J., Dong, Y., & Xi, J. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01345-w · Cited by 46
Metadata
- Authors
- Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Liu, David R.
- ORCID
- Venue
- Nature
- Published
- 2017-11-01
- Volume
- 551
- Issue
- 7681
- Pages
- 464-471
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5726555
- OpenAlex
- W2766599608
- Cited by
- 4,184
- References
- 46
- Citations by year
- 2026: 460 · 2025: 501 · 2024: 521 · 2023: 599 · 2022: 557 · 2021: 489 · 2020: 474 · 2019: 332 · 2018: 237 · 2017: 8
- FWCI
- 117.56
- Type
- journal article
- Language
- en
- Update notices
- correction (2018-05-02)
- Open access
- green
- europepmc.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Human Genome Research Institute (RM1HG009490)
- National Institute of General Medical Sciences (T32GM008313, F32GM106621, R35GM118062, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- adenine base editors, base editing, cytosine deamination, CRISPR/Cas9, directed evolution, protein engineering, transition mutations, point mutations, single nucleotide polymorphisms
- MeSH terms
- Gene Editing, Adenosine Deaminase, DNA, Humans, Models, Molecular, Genome, Human, Base Pairing, Polymorphism, Single Nucleotide, Cell Line, Tumor, DNA Cleavage, HEK293 Cells, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
